Dr. Eric Duncavage, MD

NPI: 1992898688
Total Payments
$71,955
2024 Payments
$12,465
Companies
13
Transactions
60
Medicare Patients
4,892
Medicare Billing
$217,616

Payment Breakdown by Category

Consulting$51,386 (71.4%)
Other$14,430 (20.1%)
Travel$4,315 (6.0%)
Food & Beverage$1,151 (1.6%)
Research$525.00 (0.7%)
Education$149.00 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $51,386 13 71.4%
Honoraria $8,508 4 11.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,922 2 8.2%
Travel and Lodging $4,315 19 6.0%
Food and Beverage $1,151 18 1.6%
Unspecified $525.00 1 0.7%
Education $149.00 3 0.2%

Payments by Type

General
$71,430
59 transactions
Research
$525.00
1 transactions

Top Paying Companies

Company Total Records Latest Year
VERTEX PHARMACEUTICALS INCORPORATED $30,476 6 $0 (2024)
Blueprint Medicines Corporation $9,547 14 $0 (2024)
AbbVie Inc. $8,826 13 $0 (2023)
Illumina, Inc. $5,973 3 $0 (2024)
Acceleron Pharma, Inc. $5,490 1 $0 (2020)
E.R. Squibb & Sons, L.L.C. $3,717 6 $0 (2019)
Eli Lilly and Company $2,468 2 $0 (2019)
Genentech, Inc. $1,695 1 $0 (2022)
Daiichi Sankyo Inc. $1,665 1 $0 (2023)
Agilent Technologies, Inc. $1,145 4 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,465 12 Blueprint Medicines Corporation ($5,702)
2023 $14,991 7 Vertex Pharmaceuticals Incorporated ($8,542)
2022 $23,619 10 Vertex Pharmaceuticals Incorporated ($18,256)
2021 $90.50 2 Blueprint Medicines Corporation ($90.50)
2020 $5,490 1 Acceleron Pharma, Inc. ($5,490)
2019 $6,279 9 E.R. Squibb & Sons, L.L.C. ($3,717)
2018 $720.78 7 Abbott Laboratories ($720.78)
2017 $8,301 12 AbbVie, Inc. ($8,301)

All Payment Transactions

60 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/12/2024 Illumina, Inc. Genetic Disease Research (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,946.00 General
Category: Genetics
12/12/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $382.94 General
12/12/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $80.00 General
12/03/2024 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $4,312.00 General
12/03/2024 Blueprint Medicines Corporation Travel and Lodging Cash or cash equivalent $137.48 General
12/03/2024 Blueprint Medicines Corporation Food and Beverage Cash or cash equivalent $38.77 General
11/19/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $360.47 General
11/19/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $279.97 General
11/19/2024 Blueprint Medicines Corporation Travel and Lodging In-kind items and services $80.00 General
11/15/2024 Blueprint Medicines Corporation Food and Beverage In-kind items and services $29.87 General
09/09/2024 Beckman Coulter, Inc. Food and Beverage In-kind items and services $139.13 General
01/10/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $3,677.96 General
12/07/2023 Illumina, Inc. Oncology Testing (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,976.00 General
Category: Genetics
12/07/2023 Illumina, Inc. Oncology Testing (Device) Travel and Lodging In-kind items and services $50.83 General
Category: Genetics
10/25/2023 Daiichi Sankyo Inc. Consulting Fee Cash or cash equivalent $1,665.00 General
07/25/2023 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $1,232.00 General
06/21/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $3,166.67 General
04/27/2023 AbbVie Inc. VENCLEXTA (Drug) Cash or cash equivalent $525.00 Research
Study: Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (Verona) • Category: ONCOLOGY
01/04/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $5,375.00 General
11/01/2022 Agilent Technologies, Inc. Consulting Fee Cash or cash equivalent $500.00 General
11/01/2022 Agilent Technologies, Inc. Honoraria Cash or cash equivalent $500.00 General
11/01/2022 Agilent Technologies, Inc. Food and Beverage In-kind items and services $125.00 General
11/01/2022 Agilent Technologies, Inc. Travel and Lodging In-kind items and services $20.00 General
10/21/2022 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $2,464.00 General
09/26/2022 Blueprint Medicines Corporation Education In-kind items and services $58.50 General

Research Studies & Clinical Trials

Study Name Company Amount Records
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome (Verona) AbbVie Inc. $525.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,222 2,128 $332,690 $54,208
2022 15 1,154 2,078 $334,040 $54,887
2021 16 1,212 1,987 $318,232 $54,353
2020 16 1,304 1,944 $300,500 $54,169
Total Patients
4,892
Total Services
8,137
Medicare Billing
$217,616
Procedure Codes
62

All Medicare Procedures & Services

62 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Facility 2023 137 146 $54,750 $9,499 17.3%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 143 293 $67,390 $8,370 12.4%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2023 70 295 $39,825 $6,496 16.3%
88319 Evaluation of specimen enzymes Facility 2023 137 307 $27,630 $6,324 22.9%
85097 Bone marrow, smear interpretation Facility 2023 135 143 $39,325 $5,285 13.4%
88360 Microscopic genetic analysis of tumor, manual Facility 2023 79 144 $28,800 $4,679 16.2%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2023 137 394 $19,700 $3,674 18.7%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 89 93 $13,950 $2,524 18.1%
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers Facility 2023 46 51 $14,280 $2,392 16.7%
88311 Preparation of tissue for examination by removing any calcium present Facility 2023 140 148 $6,660 $1,421 21.3%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2023 20 22 $6,820 $1,411 20.7%
85060 Blood smear interpretation by physician with written report Facility 2023 49 52 $3,900 $988.52 25.3%
88187 Flow cytometry technique for dna or cell analysis, 2 to 8 markers Facility 2023 18 18 $4,050 $503.10 12.4%
88368 Microscopic genetic analysis of tissue, manual, initial procedure Facility 2023 11 11 $2,805 $358.05 12.8%
88369 Microscopic genetic analysis of tissue, manual, each additional procedure Facility 2023 11 11 $2,805 $284.13 10.1%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Facility 2022 138 145 $54,375 $9,180 16.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 126 269 $61,870 $7,731 12.5%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2022 72 336 $45,360 $7,522 16.6%
88319 Evaluation of specimen enzymes Facility 2022 120 276 $24,840 $5,816 23.4%
88360 Microscopic genetic analysis of tumor, manual Facility 2022 86 157 $31,400 $5,218 16.6%
85097 Bone marrow, smear interpretation Facility 2022 120 130 $35,750 $4,816 13.5%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2022 121 355 $17,750 $3,412 19.2%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2022 85 92 $13,800 $2,546 18.4%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2022 32 38 $11,780 $2,496 21.2%
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers Facility 2022 42 47 $13,160 $2,307 17.5%

About Dr. Eric Duncavage, MD

Dr. Eric Duncavage, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992898688.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Duncavage, MD has received a total of $71,955 in payments from pharmaceutical and medical device companies, with $12,465 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($51,386).

As a Medicare-enrolled provider, Duncavage has provided services to 4,892 Medicare beneficiaries, totaling 8,137 services with total Medicare billing of $217,616. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.

Practice Information

Products in Payments

  • Reblozyl (Drug) $5,490
  • OPDIVO (Biological) $3,717
  • Oncology Testing (Device) $3,027
  • Genetic Disease Research (Device) $2,946
  • TECENTRIQ (Biological) $1,695
  • VENCLEXTA (Drug) $525.00
  • RealTime BRAF (Device) $378.06
  • Vysis ALK (Device) $342.72
  • VYXEOS (Drug) $94.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Saint Louis